Reference
Leung M, et al. PIK3CA inhibitor, alpelisib, and diabetic ketoacidosis: A case study on choosing wisely. Journal of Oncology Pharmacy Practice 27 (Suppl.): 9, No. 5, Jul 2021. Available from: URL: http://doi.org/10.1177/10781552211012588 [abstract]
Rights and permissions
About this article
Cite this article
Alpelisib. Reactions Weekly 1866, 30 (2021). https://doi.org/10.1007/s40278-021-99726-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-99726-8